{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:03:11Z","timestamp":1774123391413,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1007\/s10096-006-0183-2","type":"journal-article","created":{"date-parts":[[2006,8,3]],"date-time":"2006-08-03T06:17:26Z","timestamp":1154585846000},"page":"518-521","source":"Crossref","is-referenced-by-count":43,"title":["Addition of a macrolide to a \u00df-lactam in bacteremic pneumococcal pneumonia"],"prefix":"10.1007","volume":"25","author":[{"given":"R.","family":"Dwyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5.","family":"\u00d6rtqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Aufwerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Henriques Normark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.J.","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Mufson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Woodhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"\u00c5lenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,4]]},"reference":[{"key":"183_CR1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/315760","volume":"182","author":"M Kalin","year":"2000","unstructured":"Kalin M, \u00d6rtqvist \u00c5, Almela M et al (2000) Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 182:840\u2013847","journal-title":"J Infect Dis"},{"key":"183_CR2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","volume":"31","author":"JG Bartlett","year":"2000","unstructured":"Bartlett JG, Dowell SF, Mandell LA, File TM, Musher DM, Fine MJ (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31:347\u2013382","journal-title":"Clin Infect Dis"},{"key":"183_CR3","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","volume":"159","author":"PP Gleason","year":"1999","unstructured":"Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ (1999) Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumoniae. Arch Intern Med 159:2562\u20132572","journal-title":"Arch Intern Med"},{"key":"183_CR4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1345\/aph.19174","volume":"34","author":"V Dudas","year":"2000","unstructured":"Dudas V, Hopefl A, Jacobs R, Guglielmo JB (2000) Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother 34:446\u2013452","journal-title":"Ann Pharmacother"},{"key":"183_CR5","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1378\/chest.119.5.1420","volume":"119","author":"PM Houck","year":"2001","unstructured":"Houck PM, MacLehose RF, Niederman MS, Lowery JK (2001) Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states. Chest 119:1420\u20131426","journal-title":"Chest"},{"key":"183_CR6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.123.5.1503","volume":"123","author":"RB Brown","year":"2003","unstructured":"Brown RB, Iannini P, Gross P, Kunkel M (2003) Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia. Chest 123:1503\u20131511","journal-title":"Chest"},{"issue":"Suppl 1A","key":"183_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9343(99)00098-4","volume":"107","author":"MA Mufson","year":"1999","unstructured":"Mufson MA, Stanek RJ (1999) Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study. Am J Med 107(Suppl 1A):34\u201343","journal-title":"Am J Med"},{"key":"183_CR8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","volume":"36","author":"JA Martinez","year":"2003","unstructured":"Martinez JA, Horcajada JP, Almela M et al (2003) Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 36:389\u2013395","journal-title":"Clin Infect Dis"},{"key":"183_CR9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818\u2013829","journal-title":"Crit Care Med"},{"key":"183_CR10","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s10096-005-0018-6","volume":"24","author":"S Harbarth","year":"2005","unstructured":"Harbarth S, Garbino J, Pugin J, Romand JA, Pittet D (2005) Lack of effect of combination therapy on mortality in patients with pneumococcal sepsis. Eur J Clin Microbiol Infect Dis 24:688\u2013690","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"183_CR11","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","volume":"161","author":"GW Waterer","year":"2001","unstructured":"Waterer GW, Somes GW, Wunderink RG (2001) Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 161:1837\u20131842","journal-title":"Arch Intern Med"},{"key":"183_CR12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","volume":"170","author":"LM Baddour","year":"2004","unstructured":"Baddour LM, Yu VL, Klugman KP, Feldman C et al (2004) Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 170:440\u2013444","journal-title":"Am J Respir Crit Care Med"},{"key":"183_CR13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1086\/367545","volume":"36","author":"TM File","year":"2003","unstructured":"File TM, Mandell LA (2003) What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? Editorial commentary. Clin Infect Dis 36:396\u2013397","journal-title":"Clin Infect Dis"},{"key":"183_CR14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/341771","volume":"35","author":"MJ Tan","year":"2002","unstructured":"Tan MJ, Tan JS, File M (2002) Legionnaires disease with bacteremic coinfection. Clin Infect Dis 35:533\u2013539","journal-title":"Clin Infect Dis"},{"key":"183_CR15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1469-0691.2002.00477.x","volume":"8","author":"B Henriques Normark","year":"2002","unstructured":"Henriques Normark B, Normark S (2002) Antibiotic tolerance in pneumococci. Clin Microbiol Infect 8:613\u2013622","journal-title":"Clin Microbiol Infect"},{"key":"183_CR16","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.47.3.1151-1153.2003","volume":"47","author":"E Lin","year":"2003","unstructured":"Lin E, Stanek RJ, Mufson MA (2003) Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro. Antimicrob Agents Chemother 47:1151\u20131153","journal-title":"Antimicrob Agents Chemother"},{"key":"183_CR17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/46.6.973","volume":"46","author":"HK Johansen","year":"2000","unstructured":"Johansen HK, Jensen TG, Dessau RB, Lundgren B, Frimodt-M\u00f6ller N (2000) Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo. J Antimicrob Chemother 46:973\u2013980","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-006-0183-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-006-0183-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-006-0183-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:30:24Z","timestamp":1559107824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-006-0183-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1007\/s10096-006-0183-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}